Global Nivolumab Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Nivolumab market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Nivolumab market are covered in Chapter 9:
Ono Pharmaceutical
Bristol-Myers Squibb
In Chapter 5 and Chapter 7.3, based on types, the Nivolumab market from 2017 to 2027 is primarily split into:
Injection 4mL
Injection 10mL
In Chapter 6 and Chapter 7.4, based on applications, the Nivolumab market from 2017 to 2027 covers:
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Nivolumab market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Nivolumab Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Nivolumab market are covered in Chapter 9:
Ono Pharmaceutical
Bristol-Myers Squibb
In Chapter 5 and Chapter 7.3, based on types, the Nivolumab market from 2017 to 2027 is primarily split into:
Injection 4mL
Injection 10mL
In Chapter 6 and Chapter 7.4, based on applications, the Nivolumab market from 2017 to 2027 covers:
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Nivolumab market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Nivolumab Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 NIVOLUMAB MARKET OVERVIEW
1.1 Product Overview and Scope of Nivolumab Market
1.2 Nivolumab Market Segment by Type
1.2.1 Global Nivolumab Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Nivolumab Market Segment by Application
1.3.1 Nivolumab Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Nivolumab Market, Region Wise (2017-2027)
1.4.1 Global Nivolumab Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Nivolumab Market Status and Prospect (2017-2027)
1.4.3 Europe Nivolumab Market Status and Prospect (2017-2027)
1.4.4 China Nivolumab Market Status and Prospect (2017-2027)
1.4.5 Japan Nivolumab Market Status and Prospect (2017-2027)
1.4.6 India Nivolumab Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Nivolumab Market Status and Prospect (2017-2027)
1.4.8 Latin America Nivolumab Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Nivolumab Market Status and Prospect (2017-2027)
1.5 Global Market Size of Nivolumab (2017-2027)
1.5.1 Global Nivolumab Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Nivolumab Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Nivolumab Market
2 INDUSTRY OUTLOOK
2.1 Nivolumab Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Nivolumab Market Drivers Analysis
2.4 Nivolumab Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Nivolumab Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Nivolumab Industry Development
3 GLOBAL NIVOLUMAB MARKET LANDSCAPE BY PLAYER
3.1 Global Nivolumab Sales Volume and Share by Player (2017-2022)
3.2 Global Nivolumab Revenue and Market Share by Player (2017-2022)
3.3 Global Nivolumab Average Price by Player (2017-2022)
3.4 Global Nivolumab Gross Margin by Player (2017-2022)
3.5 Nivolumab Market Competitive Situation and Trends
3.5.1 Nivolumab Market Concentration Rate
3.5.2 Nivolumab Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NIVOLUMAB SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Nivolumab Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Nivolumab Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Nivolumab Market Under COVID-19
4.5 Europe Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Nivolumab Market Under COVID-19
4.6 China Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Nivolumab Market Under COVID-19
4.7 Japan Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Nivolumab Market Under COVID-19
4.8 India Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Nivolumab Market Under COVID-19
4.9 Southeast Asia Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Nivolumab Market Under COVID-19
4.10 Latin America Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Nivolumab Market Under COVID-19
4.11 Middle East and Africa Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Nivolumab Market Under COVID-19
5 GLOBAL NIVOLUMAB SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Nivolumab Sales Volume and Market Share by Type (2017-2022)
5.2 Global Nivolumab Revenue and Market Share by Type (2017-2022)
5.3 Global Nivolumab Price by Type (2017-2022)
5.4 Global Nivolumab Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Nivolumab Sales Volume, Revenue and Growth Rate of Injection 4mL (2017-2022)
5.4.2 Global Nivolumab Sales Volume, Revenue and Growth Rate of Injection 10mL (2017-2022)
6 GLOBAL NIVOLUMAB MARKET ANALYSIS BY APPLICATION
6.1 Global Nivolumab Consumption and Market Share by Application (2017-2022)
6.2 Global Nivolumab Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Nivolumab Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Nivolumab Consumption and Growth Rate of Unresectable Melanoma (2017-2022)
6.3.2 Global Nivolumab Consumption and Growth Rate of Metastatic Melanoma (2017-2022)
6.3.3 Global Nivolumab Consumption and Growth Rate of Metastatic Squamous NSCLC (2017-2022)
6.3.4 Global Nivolumab Consumption and Growth Rate of Classical Hodgkin Lymphoma (2017-2022)
6.3.5 Global Nivolumab Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
6.3.6 Global Nivolumab Consumption and Growth Rate of Other (2017-2022)
7 GLOBAL NIVOLUMAB MARKET FORECAST (2022-2027)
7.1 Global Nivolumab Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Nivolumab Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Nivolumab Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Nivolumab Price and Trend Forecast (2022-2027)
7.2 Global Nivolumab Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Nivolumab Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Nivolumab Revenue and Growth Rate of Injection 4mL (2022-2027)
7.3.2 Global Nivolumab Revenue and Growth Rate of Injection 10mL (2022-2027)
7.4 Global Nivolumab Consumption Forecast by Application (2022-2027)
7.4.1 Global Nivolumab Consumption Value and Growth Rate of Unresectable Melanoma(2022-2027)
7.4.2 Global Nivolumab Consumption Value and Growth Rate of Metastatic Melanoma(2022-2027)
7.4.3 Global Nivolumab Consumption Value and Growth Rate of Metastatic Squamous NSCLC(2022-2027)
7.4.4 Global Nivolumab Consumption Value and Growth Rate of Classical Hodgkin Lymphoma(2022-2027)
7.4.5 Global Nivolumab Consumption Value and Growth Rate of Renal Cell Carcinoma(2022-2027)
7.4.6 Global Nivolumab Consumption Value and Growth Rate of Other(2022-2027)
7.5 Nivolumab Market Forecast Under COVID-19
8 NIVOLUMAB MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Nivolumab Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Nivolumab Analysis
8.6 Major Downstream Buyers of Nivolumab Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Nivolumab Industry
9 PLAYERS PROFILES
9.1 Ono Pharmaceutical
9.1.1 Ono Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Nivolumab Product Profiles, Application and Specification
9.1.3 Ono Pharmaceutical Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Nivolumab Product Profiles, Application and Specification
9.2.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Nivolumab Market
1.2 Nivolumab Market Segment by Type
1.2.1 Global Nivolumab Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Nivolumab Market Segment by Application
1.3.1 Nivolumab Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Nivolumab Market, Region Wise (2017-2027)
1.4.1 Global Nivolumab Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Nivolumab Market Status and Prospect (2017-2027)
1.4.3 Europe Nivolumab Market Status and Prospect (2017-2027)
1.4.4 China Nivolumab Market Status and Prospect (2017-2027)
1.4.5 Japan Nivolumab Market Status and Prospect (2017-2027)
1.4.6 India Nivolumab Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Nivolumab Market Status and Prospect (2017-2027)
1.4.8 Latin America Nivolumab Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Nivolumab Market Status and Prospect (2017-2027)
1.5 Global Market Size of Nivolumab (2017-2027)
1.5.1 Global Nivolumab Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Nivolumab Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Nivolumab Market
2 INDUSTRY OUTLOOK
2.1 Nivolumab Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Nivolumab Market Drivers Analysis
2.4 Nivolumab Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Nivolumab Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Nivolumab Industry Development
3 GLOBAL NIVOLUMAB MARKET LANDSCAPE BY PLAYER
3.1 Global Nivolumab Sales Volume and Share by Player (2017-2022)
3.2 Global Nivolumab Revenue and Market Share by Player (2017-2022)
3.3 Global Nivolumab Average Price by Player (2017-2022)
3.4 Global Nivolumab Gross Margin by Player (2017-2022)
3.5 Nivolumab Market Competitive Situation and Trends
3.5.1 Nivolumab Market Concentration Rate
3.5.2 Nivolumab Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL NIVOLUMAB SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Nivolumab Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Nivolumab Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Nivolumab Market Under COVID-19
4.5 Europe Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Nivolumab Market Under COVID-19
4.6 China Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Nivolumab Market Under COVID-19
4.7 Japan Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Nivolumab Market Under COVID-19
4.8 India Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Nivolumab Market Under COVID-19
4.9 Southeast Asia Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Nivolumab Market Under COVID-19
4.10 Latin America Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Nivolumab Market Under COVID-19
4.11 Middle East and Africa Nivolumab Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Nivolumab Market Under COVID-19
5 GLOBAL NIVOLUMAB SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Nivolumab Sales Volume and Market Share by Type (2017-2022)
5.2 Global Nivolumab Revenue and Market Share by Type (2017-2022)
5.3 Global Nivolumab Price by Type (2017-2022)
5.4 Global Nivolumab Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Nivolumab Sales Volume, Revenue and Growth Rate of Injection 4mL (2017-2022)
5.4.2 Global Nivolumab Sales Volume, Revenue and Growth Rate of Injection 10mL (2017-2022)
6 GLOBAL NIVOLUMAB MARKET ANALYSIS BY APPLICATION
6.1 Global Nivolumab Consumption and Market Share by Application (2017-2022)
6.2 Global Nivolumab Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Nivolumab Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Nivolumab Consumption and Growth Rate of Unresectable Melanoma (2017-2022)
6.3.2 Global Nivolumab Consumption and Growth Rate of Metastatic Melanoma (2017-2022)
6.3.3 Global Nivolumab Consumption and Growth Rate of Metastatic Squamous NSCLC (2017-2022)
6.3.4 Global Nivolumab Consumption and Growth Rate of Classical Hodgkin Lymphoma (2017-2022)
6.3.5 Global Nivolumab Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
6.3.6 Global Nivolumab Consumption and Growth Rate of Other (2017-2022)
7 GLOBAL NIVOLUMAB MARKET FORECAST (2022-2027)
7.1 Global Nivolumab Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Nivolumab Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Nivolumab Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Nivolumab Price and Trend Forecast (2022-2027)
7.2 Global Nivolumab Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Nivolumab Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Nivolumab Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Nivolumab Revenue and Growth Rate of Injection 4mL (2022-2027)
7.3.2 Global Nivolumab Revenue and Growth Rate of Injection 10mL (2022-2027)
7.4 Global Nivolumab Consumption Forecast by Application (2022-2027)
7.4.1 Global Nivolumab Consumption Value and Growth Rate of Unresectable Melanoma(2022-2027)
7.4.2 Global Nivolumab Consumption Value and Growth Rate of Metastatic Melanoma(2022-2027)
7.4.3 Global Nivolumab Consumption Value and Growth Rate of Metastatic Squamous NSCLC(2022-2027)
7.4.4 Global Nivolumab Consumption Value and Growth Rate of Classical Hodgkin Lymphoma(2022-2027)
7.4.5 Global Nivolumab Consumption Value and Growth Rate of Renal Cell Carcinoma(2022-2027)
7.4.6 Global Nivolumab Consumption Value and Growth Rate of Other(2022-2027)
7.5 Nivolumab Market Forecast Under COVID-19
8 NIVOLUMAB MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Nivolumab Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Nivolumab Analysis
8.6 Major Downstream Buyers of Nivolumab Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Nivolumab Industry
9 PLAYERS PROFILES
9.1 Ono Pharmaceutical
9.1.1 Ono Pharmaceutical Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Nivolumab Product Profiles, Application and Specification
9.1.3 Ono Pharmaceutical Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Bristol-Myers Squibb
9.2.1 Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Nivolumab Product Profiles, Application and Specification
9.2.3 Bristol-Myers Squibb Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Nivolumab Product Picture
Table Global Nivolumab Market Sales Volume and CAGR (%) Comparison by Type
Table Nivolumab Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Nivolumab Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Nivolumab Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Nivolumab Industry Development
Table Global Nivolumab Sales Volume by Player (2017-2022)
Table Global Nivolumab Sales Volume Share by Player (2017-2022)
Figure Global Nivolumab Sales Volume Share by Player in 2021
Table Nivolumab Revenue (Million USD) by Player (2017-2022)
Table Nivolumab Revenue Market Share by Player (2017-2022)
Table Nivolumab Price by Player (2017-2022)
Table Nivolumab Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Nivolumab Sales Volume, Region Wise (2017-2022)
Table Global Nivolumab Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Sales Volume Market Share, Region Wise in 2021
Table Global Nivolumab Revenue (Million USD), Region Wise (2017-2022)
Table Global Nivolumab Revenue Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Revenue Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Revenue Market Share, Region Wise in 2021
Table Global Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Nivolumab Sales Volume by Type (2017-2022)
Table Global Nivolumab Sales Volume Market Share by Type (2017-2022)
Figure Global Nivolumab Sales Volume Market Share by Type in 2021
Table Global Nivolumab Revenue (Million USD) by Type (2017-2022)
Table Global Nivolumab Revenue Market Share by Type (2017-2022)
Figure Global Nivolumab Revenue Market Share by Type in 2021
Table Nivolumab Price by Type (2017-2022)
Figure Global Nivolumab Sales Volume and Growth Rate of Injection 4mL (2017-2022)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 4mL (2017-2022)
Figure Global Nivolumab Sales Volume and Growth Rate of Injection 10mL (2017-2022)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 10mL (2017-2022)
Table Global Nivolumab Consumption by Application (2017-2022)
Table Global Nivolumab Consumption Market Share by Application (2017-2022)
Table Global Nivolumab Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Nivolumab Consumption Revenue Market Share by Application (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Unresectable Melanoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Metastatic Melanoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Metastatic Squamous NSCLC (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Classical Hodgkin Lymphoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Other (2017-2022)
Figure Global Nivolumab Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Nivolumab Price and Trend Forecast (2022-2027)
Figure USA Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Nivolumab Market Sales Volume Forecast, by Type
Table Global Nivolumab Sales Volume Market Share Forecast, by Type
Table Global Nivolumab Market Revenue (Million USD) Forecast, by Type
Table Global Nivolumab Revenue Market Share Forecast, by Type
Table Global Nivolumab Price Forecast, by Type
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 4mL (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 4mL (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 10mL (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 10mL (2022-2027)
Table Global Nivolumab Market Consumption Forecast, by Application
Table Global Nivolumab Consumption Market Share Forecast, by Application
Table Global Nivolumab Market Revenue (Million USD) Forecast, by Application
Table Global Nivolumab Revenue Market Share Forecast, by Application
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Unresectable Melanoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Metastatic Melanoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Metastatic Squamous NSCLC (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Classical Hodgkin Lymphoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Renal Cell Carcinoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Nivolumab Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Ono Pharmaceutical Profile
Table Ono Pharmaceutical Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ono Pharmaceutical Nivolumab Sales Volume and Growth Rate
Figure Ono Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Nivolumab Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
Figure Nivolumab Product Picture
Table Global Nivolumab Market Sales Volume and CAGR (%) Comparison by Type
Table Nivolumab Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Nivolumab Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Nivolumab Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Nivolumab Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Nivolumab Industry Development
Table Global Nivolumab Sales Volume by Player (2017-2022)
Table Global Nivolumab Sales Volume Share by Player (2017-2022)
Figure Global Nivolumab Sales Volume Share by Player in 2021
Table Nivolumab Revenue (Million USD) by Player (2017-2022)
Table Nivolumab Revenue Market Share by Player (2017-2022)
Table Nivolumab Price by Player (2017-2022)
Table Nivolumab Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Nivolumab Sales Volume, Region Wise (2017-2022)
Table Global Nivolumab Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Sales Volume Market Share, Region Wise in 2021
Table Global Nivolumab Revenue (Million USD), Region Wise (2017-2022)
Table Global Nivolumab Revenue Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Revenue Market Share, Region Wise (2017-2022)
Figure Global Nivolumab Revenue Market Share, Region Wise in 2021
Table Global Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Nivolumab Sales Volume by Type (2017-2022)
Table Global Nivolumab Sales Volume Market Share by Type (2017-2022)
Figure Global Nivolumab Sales Volume Market Share by Type in 2021
Table Global Nivolumab Revenue (Million USD) by Type (2017-2022)
Table Global Nivolumab Revenue Market Share by Type (2017-2022)
Figure Global Nivolumab Revenue Market Share by Type in 2021
Table Nivolumab Price by Type (2017-2022)
Figure Global Nivolumab Sales Volume and Growth Rate of Injection 4mL (2017-2022)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 4mL (2017-2022)
Figure Global Nivolumab Sales Volume and Growth Rate of Injection 10mL (2017-2022)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 10mL (2017-2022)
Table Global Nivolumab Consumption by Application (2017-2022)
Table Global Nivolumab Consumption Market Share by Application (2017-2022)
Table Global Nivolumab Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Nivolumab Consumption Revenue Market Share by Application (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Unresectable Melanoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Metastatic Melanoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Metastatic Squamous NSCLC (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Classical Hodgkin Lymphoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Renal Cell Carcinoma (2017-2022)
Table Global Nivolumab Consumption and Growth Rate of Other (2017-2022)
Figure Global Nivolumab Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Nivolumab Price and Trend Forecast (2022-2027)
Figure USA Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nivolumab Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Nivolumab Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Nivolumab Market Sales Volume Forecast, by Type
Table Global Nivolumab Sales Volume Market Share Forecast, by Type
Table Global Nivolumab Market Revenue (Million USD) Forecast, by Type
Table Global Nivolumab Revenue Market Share Forecast, by Type
Table Global Nivolumab Price Forecast, by Type
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 4mL (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 4mL (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 10mL (2022-2027)
Figure Global Nivolumab Revenue (Million USD) and Growth Rate of Injection 10mL (2022-2027)
Table Global Nivolumab Market Consumption Forecast, by Application
Table Global Nivolumab Consumption Market Share Forecast, by Application
Table Global Nivolumab Market Revenue (Million USD) Forecast, by Application
Table Global Nivolumab Revenue Market Share Forecast, by Application
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Unresectable Melanoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Metastatic Melanoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Metastatic Squamous NSCLC (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Classical Hodgkin Lymphoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Renal Cell Carcinoma (2022-2027)
Figure Global Nivolumab Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Nivolumab Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Ono Pharmaceutical Profile
Table Ono Pharmaceutical Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Ono Pharmaceutical Nivolumab Sales Volume and Growth Rate
Figure Ono Pharmaceutical Revenue (Million USD) Market Share 2017-2022
Table Bristol-Myers Squibb Profile
Table Bristol-Myers Squibb Nivolumab Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Bristol-Myers Squibb Nivolumab Sales Volume and Growth Rate
Figure Bristol-Myers Squibb Revenue (Million USD) Market Share 2017-2022
